Related Experiment Videos
Lysis of human alveolar macrophages by lymphokine-activated killer cells
M Maruyama1, A Kawasaki, H Suzuki
1First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, School of Medicine, Japan.
Abstract:
In order to determine if human LAK cells were cytotoxic against autologous AM phi, we studied the ability of human peripheral blood MNCs, stimulated in vitro with recombinant human IL-2, to lyse AM phi in a four-hour 51Cr-release assay. These cells showed significant cytotoxicity against autologous AM phi. The AM phi which had been cultured for four days served as better targets than freshly isolated AM phi. Kinetic study showed that the lysis of AM phi was proportional to the incubation time of MNCs with IL-2 and that LAK cells against AM phi required two days of in vitro culture with IL-2 for their induction. Freshly isolated MNCs did not lyse AM phi but did lyse K562 target cells, indicating that AM phi are natural killer-resistant. The phenotypes of effector cells against AM phi were found to be CD8+ or CD16+ (or both). These studies indicate that IL-2 can generate LAK cells against autologous AM phi, and this cytolytic activity must be taken into account when IL-2 or LAK cells are used for immunomodulation in patients with cancer.
Insights
Interleukin-2 (IL-2) can generate Lymphokine-Activated Killer (LAK) cells that effectively kill autologous alveolar macrophages (AM phi). This immune response is crucial for understanding IL-2-based cancer immunotherapies.
Area of Science:
- Immunology
- Cell Biology
- Cancer Therapy
Background:
- Alveolar macrophages (AM phi) play a role in immune responses.
- Lymphokine-Activated Killer (LAK) cells are immune cells with cytotoxic potential.
- Interleukin-2 (IL-2) is a cytokine used in cancer immunotherapy.
Purpose of the Study:
- To investigate the cytotoxic activity of human LAK cells against autologous AM phi.
- To determine the conditions required for LAK cell generation against AM phi.
- To identify the phenotypes of effector cells involved in AM phi lysis.
Main Methods:
- Human peripheral blood mononuclear cells (MNCs) were stimulated in vitro with IL-2.
- Cytotoxicity was assessed using a 4-hour 51Cr-release assay.
- Phenotypic analysis of effector cells was performed.
Main Results:
- IL-2-stimulated MNCs demonstrated significant cytotoxicity against autologous AM phi.
- Cultured AM phi (4 days) were more susceptible targets than freshly isolated AM phi.
- LAK cell induction against AM phi required 2 days of in vitro culture with IL-2.
- Freshly isolated MNCs did not lyse AM phi, indicating natural killer resistance.
- Effector cells against AM phi were identified as CD8+ or CD16+ (or both).
Conclusions:
- IL-2 can effectively generate LAK cells capable of lysing autologous AM phi.
- The immunomodulatory effects of IL-2 and LAK cells in cancer patients must consider this AM phi-lytic activity.
- Understanding this interaction is vital for optimizing IL-2-based cancer treatments.